Since the mRNA expression of CPA4 in BLCA was significantly higher than that in normal bladder tissue, we speculated that CPA4 can be regarded as a biomarker to detect BLCA from normal controls. The gene discussed is CPA4; the disease is bladder transitional cell carcinoma.